Pharmacokinetics of ceftiofur crystalline free acid after single and multiple subcutaneous administrations in healthy alpacas (Vicugna pacos)

被引:14
作者
Dechant, J. E. [1 ]
Rowe, J. D. [2 ]
Byrne, B. A. [3 ]
Wetzlich, S. E. [4 ]
Kieu, H. T. [4 ]
Tell, L. A. [4 ]
机构
[1] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA
[2] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA
[3] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA
[4] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA
关键词
DESFUROYLCEFTIOFUR; METABOLITE; DISEASE; SODIUM; PLASMA; LLAMAS;
D O I
10.1111/j.1365-2885.2012.01395.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dechant, J. E., Rowe, J. D., Byrne, B. A., Wetzlich, S. E., Kieu, H. T., Tell, L. A. Pharmacokinetics of ceftiofur crystalline free acid after single and multiple subcutaneous administrations in healthy alpacas (Vicugna pacos). J. vet. Pharmacol. Therap.36, 122129. Six adult male alpacas received one subcutaneous administration of ceftiofur crystalline free acid (CCFA) at a dosage of 6.6mg/kg. After a washout period, the same alpacas received three subcutaneous doses of 6.6mg/kg CCFA at 5-day intervals. Blood samples collected from the jugular vein before and at multiple time points after each CCFA administration were assayed for ceftiofur- and desfuroylceftiofur-related metabolite concentrations using high-performance liquid chromatography. Pharmacokinetic disposition of CCFA was analyzed by a noncompartmental approach. Mean pharmacokinetic parameters (+/- SD) following single-dose administration of CCFA were Cmax (2.7 +/- 0.9g/mL); Tmax (36 +/- 0h); area under the curve AUC0 (199.2 +/- 42.1g center dot h/mL); terminal phase rate constant z (0.02 +/- 0.003/h); and terminal phase rate constant half-life t1/2z (44.7h; harmonic). Mean terminal pharmacokinetic parameters (+/- SD) following three administrations of CCFA were Cmax (2.0 +/- 0.4g/mL); Tmax (17.3 +/- 16.3h); AUC0 (216.8 +/- 84.5g center dot h/mL); z (0.01 +/- 0.003/h); and t1/2z (65.9h; harmonic). The terminal phase rate constant and the Tmax were significantly different between single and multiple administrations. Local reactions were noted in two alpacas following multiple CCFA administrations.
引用
收藏
页码:122 / 129
页数:8
相关论文
共 30 条
  • [11] Pharmacokinetics of ceftiofur crystalline free acid after single subcutaneous administration in lactating and nonlactating domestic goats (Capra aegagrus hircus)
    Dore, Elizabeth
    Angelos, John A.
    Rowe, Joan D.
    Carlson, Jan L.
    Wetzlich, Scott E.
    Kieu, Hung T.
    Tell, Lisa A.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2011, 34 (01) : 25 - 30
  • [12] Pharmacokinetics of ceftiofur in llamas and alpacas
    Drew, ML
    Johnson, L
    Pugh, D
    Navarre, CB
    Taylor, IT
    Craigmill, AL
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2004, 27 (01) : 13 - 20
  • [13] The mutant selection window and antimicrobial resistance
    Drlica, K
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) : 11 - 17
  • [14] European Agency for the Evaluation of Medicinal Products, 2001, COND BIOEQ STUD VET
  • [15] Effects of two methods of administration on the pharmacokinetics of ceftiofur crystalline free acid in horses
    Giguere, S.
    Sturgill, T. L.
    Berghaus, L. J.
    Grover, G. S.
    Brown, S. A.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2011, 34 (02) : 193 - 196
  • [16] Pharmacokinetics of ceftiofur after single intravenous and intramuscular administration in camels (Camelus dromedarius)
    Goudah, A.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2007, 30 (04) : 371 - 374
  • [17] Pharmacokinetics of ceftiofur sodium and ceftiofur crystalline free acid in neonatal foals
    Hall, T. L.
    Tell, L. A.
    Wetzlich, S. E.
    McCormick, J. D.
    Fowler, L. W.
    Pusterla, N.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2011, 34 (04) : 403 - 409
  • [18] Dose determination and confirmation of a long-acting formulation of ceftiofur (ceftiofur crystalline free acid) administered subcutaneously for the treatment of bovine respiratory disease
    Hibbard, B
    Robb, EJ
    Chester, ST
    Dame, KJ
    Boucher, JF
    Alaniz, GR
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2002, 25 (03) : 175 - 180
  • [19] Hibbard Beth, 2002, Vet Ther, V3, P22
  • [20] JAGLAN PS, 1990, J ASSOC OFF ANA CHEM, V73, P26